These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

409 related items for PubMed ID: 21435840

  • 1. Prescription patterns of antiepileptic drugs in patients with epilepsy in a nation-wide population.
    Landmark CJ, Fossmark H, Larsson PG, Rytter E, Johannessen SI.
    Epilepsy Res; 2011 Jun; 95(1-2):51-9. PubMed ID: 21435840
    [Abstract] [Full Text] [Related]

  • 2. Antiepileptic drugs in Australia: 2002-2007.
    Hollingworth SA, Eadie MJ.
    Pharmacoepidemiol Drug Saf; 2010 Jan; 19(1):82-9. PubMed ID: 19802824
    [Abstract] [Full Text] [Related]

  • 3. Antiepileptic drugs in epilepsy and other disorders--a population-based study of prescriptions.
    Johannessen Landmark C, Larsson PG, Rytter E, Johannessen SI.
    Epilepsy Res; 2009 Nov; 87(1):31-9. PubMed ID: 19679449
    [Abstract] [Full Text] [Related]

  • 4. Changes in utilisation of antiepileptic drugs in epilepsy and non-epilepsy disorders-a pharmacoepidemiological study and clinical implications.
    Baftiu A, Johannessen Landmark C, Rusten IR, Feet SA, Johannessen SI, Larsson PG.
    Eur J Clin Pharmacol; 2016 Oct; 72(10):1245-1254. PubMed ID: 27411937
    [Abstract] [Full Text] [Related]

  • 5. Sociodemographic differences in antiepileptic drug prescriptions to adult epilepsy patients.
    Mattsson P, Tomson T, Eriksson O, Brännström L, Weitoft GR.
    Neurology; 2010 Jan 26; 74(4):295-301. PubMed ID: 20101034
    [Abstract] [Full Text] [Related]

  • 6. Pharmacokinetic variability of four newer antiepileptic drugs, lamotrigine, levetiracetam, oxcarbazepine, and topiramate: a comparison of the impact of age and comedication.
    Johannessen Landmark C, Baftiu A, Tysse I, Valsø B, Larsson PG, Rytter E, Johannessen SI.
    Ther Drug Monit; 2012 Aug 26; 34(4):440-5. PubMed ID: 22777154
    [Abstract] [Full Text] [Related]

  • 7. Age-related pattern of the antiepileptic drug utilization in active epilepsy: a population-based survey.
    Bielen I, Sruk A, Planjar-Prvan M, Cvitanović-Sojat L, Kosicek M, Bergman-Marković B, Baraba R, Butković-Soldo S.
    Coll Antropol; 2009 Jun 26; 33(2):659-63. PubMed ID: 19662794
    [Abstract] [Full Text] [Related]

  • 8. Trends in the use of antiepileptic drugs in Taiwan from 2003 to 2007: a population-based national health insurance study.
    Hsieh LP, Huang CY.
    Epilepsy Res; 2011 Sep 26; 96(1-2):81-8. PubMed ID: 21632214
    [Abstract] [Full Text] [Related]

  • 9. Antiepileptic drug utilization in Taiwan: analysis of prescription using National Health Insurance database.
    Hsieh LP, Huang CY.
    Epilepsy Res; 2009 Mar 26; 84(1):21-7. PubMed ID: 19135869
    [Abstract] [Full Text] [Related]

  • 10. Newer and older antiepileptic drug use in Southern Italy: a population-based study during the years 2003-2005.
    Alacqua M, Trifirò G, Spina E, Moretti S, Tari DU, Bramanti P, Caputi AP, Arcoraci V.
    Epilepsy Res; 2009 Jul 26; 85(1):107-13. PubMed ID: 19345564
    [Abstract] [Full Text] [Related]

  • 11. Prescribing patterns of antiepileptic drugs in Italy: a nationwide population-based study in the years 2000-2005.
    Savica R, Beghi E, Mazzaglia G, Innocenti F, Brignoli O, Cricelli C, Caputi AP, Musolino R, Spina E, Trifirò G.
    Eur J Neurol; 2007 Dec 26; 14(12):1317-21. PubMed ID: 17903210
    [Abstract] [Full Text] [Related]

  • 12. Relationship between adverse effects of antiepileptic drugs, number of coprescribed drugs, and drug load in a large cohort of consecutive patients with drug-refractory epilepsy.
    Canevini MP, De Sarro G, Galimberti CA, Gatti G, Licchetta L, Malerba A, Muscas G, La Neve A, Striano P, Perucca E, SOPHIE Study Group.
    Epilepsia; 2010 May 26; 51(5):797-804. PubMed ID: 20545754
    [Abstract] [Full Text] [Related]

  • 13. Evolving antiepileptic drug treatment in juvenile myoclonic epilepsy.
    Prasad A, Kuzniecky RI, Knowlton RC, Welty TE, Martin RC, Mendez M, Faught RE.
    Arch Neurol; 2003 Aug 26; 60(8):1100-5. PubMed ID: 12925366
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Utilisation and polypharmacy aspects of antiepileptic drugs in elderly versus younger patients with epilepsy: A pharmacoepidemiological study of CNS-active drugs in Norway, 2004-2015.
    Baftiu A, Feet SA, Larsson PG, Burns ML, Henning O, Sætre E, Molden E, Granas AG, Johannessen SI, Landmark CJ.
    Epilepsy Res; 2018 Jan 26; 139():35-42. PubMed ID: 29175562
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Clinical use of antiepileptic drugs at a referral centre for epilepsy.
    Landmark CJ, Rytter E, Johannessen SI.
    Seizure; 2007 Jun 26; 16(4):356-64. PubMed ID: 17420145
    [Abstract] [Full Text] [Related]

  • 18. Pharmacoepidemiology in community-dwelling elderly taking antiepileptic drugs.
    Berlowitz DR, Pugh MJ.
    Int Rev Neurobiol; 2007 Jun 26; 81():153-63. PubMed ID: 17433922
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Clinical consequences of generic substitution of lamotrigine for patients with epilepsy.
    LeLorier J, Duh MS, Paradis PE, Lefebvre P, Weiner J, Manjunath R, Sheehy O.
    Neurology; 2008 May 27; 70(22 Pt 2):2179-86. PubMed ID: 18505997
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.